logo

Catalyst Pharmaceutical Partners Inc. (CPRX)



Trade CPRX now with
  Date
  Headline
6/29/2021 8:15:36 AM Catalyst Pharma Appoints Molly Harper To Board
6/28/2021 8:19:19 AM Catalyst Pharma Announces License And Supply Agreement With DyDo Pharma For Commercialization Of Firdapse In Japan
8/11/2020 6:17:55 AM Catalyst Pharma: USPTO Issues Notice Of Allowance Of Patent Application For Methods Of Administering 3,4-Diaminopyridine
6/23/2020 8:09:12 AM Catalyst Pharmaceuticals Promotes Jeffrey Del Carmen To Chief Commercial Officer
4/8/2020 6:36:02 AM Catalyst Pharma Provides Update On Impact Of COVID-19 Pandemic On Its Business Activities
1/6/2020 8:12:46 AM Catalyst Pharmaceuticals Expects Firdapse 2019 Net Product Revenues To Be $102 Mln